Author(s): Li G, Gerlovin H, Figueroa Muñiz MJ, Wise JK, Madenci AL, Robins JM, Aslan M, Cho K, Gaziano JM, Lipsitch M, Casas JP, Hernán MA, Dickerman BA|Journal: Epidemiology|PMID:38109485| March 2024
Observational studies are used for estimating vaccine effectiveness under real-world conditions. The practical performance of two common approaches - cohort…
Author(s): Cohen-Stavi CJ, Magen O, Barda N, Yaron S, Peretz A, Netzer D, Giaquinto C, Judd A, Leibovici L, Hernán MA, Lipsitch M, Reis BY, Balicer RD, Dagan N|Journal: N Engl J Med|PMID:35767475| July 2022
Limited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and specifically against…
Author(s): Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernán MA, Lipsitch M, Reis BY, Balicer RD, Dagan N|Journal: N Engl J Med|PMID:35417631| April 2022
With large waves of infection driven by the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alongside…
Author(s): De Salazar PM, Lu F, Hay JA, Gomez-Barroso D, Fernandez-Navarro P, Martinez EV, Astray-Mochales J, Amillategui R, Garcia-Fulgueiras A, Chirlaque MD, Sanchez-Migallon A, Larrauri A, Sierra MJ, Lipsitch M, Simon F, Santillana M, Hernán MA|Journal: PLoS Comput Biol|PMID:35358171| March 2022
When responding to infectious disease outbreaks, rapid and accurate estimation of the epidemic trajectory is critical. However, two common data…
Author(s): Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, Hernán MA, Lipsitch M, Hernández-Díaz S, Reis BY, Balicer RD|Journal: Nat Med|PMID:34493859| September 2021
To evaluate the effectiveness of the BNT162b2 messenger RNA vaccine in pregnant women, we conducted an observational cohort study of…
Author(s): Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, Hernán MA, Lipsitch M, Kohane I, Netzer D, Reis BY, Balicer RD|Journal: N Engl J Med|PMID:34432976| August 2021
Preapproval trials showed that messenger RNA (mRNA)-based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety…
Author(s): Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD|Journal: N Engl J Med|PMID:33626250| April 2021
As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range…
Author(s): De Salazar PM, Gomez-Barroso D, Pampaka D, Gil JM, Penalver B, Fernandez-Escobar C, Lipsitch M, Larrauri A, Goldstein E, Hernán MA|Journal: Epidemiol Infect|PMID:33081851| October 2020
During the first months of the SARS-CoV-2 epidemic in 2020, Spain implemented an initial lockdown period on March 15 followed…
